by Haemato AG | Sep 1, 2020 | Investor News
HAEMATO AG Berlin ISIN: DE0006190705/ WKN 619070 Notification concerning ordinary capital reduction in accordance with §§ 222 ff of the German Stock Corporation Act (AktG). The ordinary Annual General Meeting of our company held on 21st July 2020 decided among other... 
by Haemato AG | Aug 24, 2020 | Allgemein
In the first half of 2020, HAEMATO AG achieved an EBITDA of EUR 2,066 thousand. Sales amounted to EUR 115.8 million. In the first six months of the financial year 2020, HAEMATO AG, Berlin (ISIN: DE0006190705) achieved an IFRS group sales of EUR 115.8 million (previous... 
by Haemato AG | Jun 25, 2020 | Ad-Hoc Announcement, Allgemein, Investor News
HAEMATO AG: The Supervisory Board and the Executive Board have agreed that Mr Uwe Zimdars will leave the Executive Board of HAEMATO AG on June 30, 2020. Mr Zimdars is currently Executive Board Member of HAEMATO AG and Supervisory Board Member of M1 Kliniken AG. Due to... 
by Haemato AG | Jun 10, 2020 | Ad-Hoc Announcement
HAEMATO AG: Ad-hoc disclosure under Article 17 MAR HAEMATO AG: MPH Health Care AG brings its shares in HAEMATO AG to M1 Kliniken AG as part of a non-cash capital increase. Today MPH Health Care AG and M1 Kliniken AG informed us that MPH Health Care AG transfers all of... 
by Haemato AG | May 27, 2020 | Investor News
Due to the present imponderables HAEMATO AG will reschedule the Annual General Meeting originally intended on July 8, 2020 to a later date. Due to the current uncertainties around the COVID-19 pandemic the Executive Board and the Supervisory Board of HAEMATO AG,...
